Literature DB >> 30113898

Incorporating Prior Knowledge about Genetic Variants into the Analysis of Genetic Association Data: An Empirical Bayes Approach.

Ali Karimnezhad, David R Bickel.   

Abstract

In a genome-wide association study (GWAS), the probability that a single nucleotide polymorphism (SNP) is not associated with a disease is its local false discovery rate (LFDR). The LFDR for each SNP is relative to a reference class of SNPs. For example, the LFDR of an exonic SNP can vary widely depending on whether it is considered relative to the separate reference class of other exonic SNPs or relative to the combined reference class of all SNPs in the data set. As a result, the analysis of the data based on the combined reference class might indicate that a specific exonic SNP is associated with the disease, while using the separate reference class indicates that it is not associated, or vice versa. To address that, we introduce empirical Bayes methods that simultaneously consider a combined reference class and a separate reference class. Our simulation studies indicate that the proposed methods lead to improved performance. The new maximum entropy method achieves that by depending on the separate class when it has enough SNPs for reliable LFDR estimation and depending solely on the combined class otherwise. We used the new methods to analyze data from a GWAS of 2,000 cases and 3,000 controls. R functions implementing the proposed methods are available on CRAN <https://cran.r-project.org/web/packages/LFDREmpiricalBayes> and Shiny <https://empiricalbayes.shinyapps.io/lfdrempiricalbayesapp>.

Mesh:

Year:  2018        PMID: 30113898     DOI: 10.1109/TCBB.2018.2865420

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.710


  1 in total

1.  Estimating the local false discovery rate via a bootstrap solution to the reference class problem.

Authors:  Farnoosh Abbas-Aghababazadeh; Mayer Alvo; David R Bickel
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.